Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,743 | 60 | 96.5% |
| Education | $173.80 | 3 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $1,298 | 21 | $0 (2019) |
| Medtronic, Inc. | $1,285 | 16 | $0 (2024) |
| Astellas Pharma US Inc | $690.11 | 8 | $0 (2024) |
| Coloplast Corp | $340.76 | 3 | $0 (2019) |
| Cook Medical LLC | $211.38 | 2 | $0 (2024) |
| Boston Scientific Corporation | $155.99 | 1 | $0 (2024) |
| Fennec Pharmaceuticals, Inc. | $136.66 | 1 | $0 (2023) |
| Ethicon US, LLC | $131.00 | 1 | $0 (2022) |
| AbbVie, Inc. | $114.82 | 1 | $0 (2017) |
| ConvaTec Inc. | $103.81 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $698.78 | 6 | Astellas Pharma US Inc ($328.85) |
| 2023 | $533.86 | 6 | Medtronic, Inc. ($298.40) |
| 2022 | $327.04 | 7 | Medtronic, Inc. ($196.04) |
| 2021 | $753.03 | 7 | Medtronic, Inc. ($682.99) |
| 2020 | $107.63 | 2 | ConvaTec Inc. ($103.81) |
| 2019 | $823.16 | 11 | Medtronic USA, Inc. ($580.61) |
| 2018 | $705.61 | 12 | Medtronic USA, Inc. ($430.20) |
| 2017 | $967.34 | 12 | Medtronic USA, Inc. ($287.08) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/28/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $158.87 | General |
| Category: Oncology | ||||||
| 07/17/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $107.73 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 03/04/2024 | Boston Scientific Corporation | AdVance XP (Device) | Food and Beverage | In-kind items and services | $155.99 | General |
| Category: AdVance_URO | ||||||
| 01/18/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 01/18/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $69.99 | General |
| 01/10/2024 | Cook Medical LLC | HEMOSPRAY (Device) | Food and Beverage | Cash or cash equivalent | $106.21 | General |
| Category: Endoscopy | ||||||
| 12/05/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $71.71 | General |
| Category: Oncology | ||||||
| 10/02/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $124.54 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 06/27/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $148.39 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 06/08/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 04/29/2023 | Fennec Pharmaceuticals, Inc. | Pedmark (Drug) | Food and Beverage | In-kind items and services | $136.66 | General |
| Category: cisplatin-induced ototoxicity | ||||||
| 11/02/2022 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/02/2022 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/30/2022 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/29/2022 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/03/2022 | Ethicon US, LLC | Echelon Flex (Device) | Food and Beverage | In-kind items and services | $131.00 | General |
| Category: Endo-Mechanical | ||||||
| 05/19/2022 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 05/10/2022 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $106.42 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/10/2021 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $164.05 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/02/2021 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $145.45 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/02/2021 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $121.19 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/01/2021 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $70.04 | General |
| Category: ONCOLOGY | ||||||
| 06/23/2021 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $168.05 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 05/07/2021 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $43.21 | General |
| Category: Sacral Nerve Stimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 134 | 149 | $65,409 | $9,250 |
| 2022 | 8 | 345 | 407 | $145,824 | $28,037 |
| 2021 | 10 | 420 | 475 | $154,777 | $37,255 |
| 2020 | 10 | 451 | 501 | $149,207 | $28,838 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 26 | 27 | $8,505 | $3,134 | 36.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 41 | 52 | $38,480 | $2,542 | 6.6% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 17 | 18 | $12,852 | $1,869 | 14.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 11 | 11 | $2,002 | $625.94 | 31.3% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 20 | 21 | $1,890 | $584.01 | 30.9% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 19 | 20 | $1,680 | $495.14 | 29.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 65 | 75 | $21,793 | $8,793 | 40.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 60 | 91 | $60,624 | $5,398 | 8.9% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 44 | 48 | $33,810 | $4,923 | 14.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 21 | 21 | $8,680 | $2,656 | 30.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 19 | $8,131 | $2,149 | 26.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2022 | 47 | 54 | $4,838 | $1,377 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 17 | 17 | $2,908 | $1,361 | 46.8% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2022 | 47 | 54 | $4,536 | $1,296 | 28.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 26 | 28 | $504.00 | $82.98 | 16.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 64 | 77 | $19,173 | $9,298 | 48.5% |
| 55700 | Biopsy of prostate gland | Facility | 2021 | 54 | 55 | $38,060 | $5,868 | 15.4% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 54 | 76 | $45,144 | $4,363 | 9.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 30 | 30 | $12,300 | $4,072 | 33.1% |
| 52235 | Destruction and/or removal of (2.0 to 5.0 centimeters) medium growths of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 11 | 12 | $9,264 | $2,976 | 32.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 24 | $9,336 | $2,924 | 31.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 32 | 36 | $5,436 | $2,761 | 50.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 19 | 19 | $5,764 | $1,914 | 33.2% |
| 76872 | Ultrasound of pelvic region through rectum | Facility | 2021 | 54 | 56 | $4,984 | $1,512 | 30.3% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Facility | 2021 | 55 | 57 | $4,788 | $1,469 | 30.7% |
About Dr. Christopher Porter, MD
Dr. Christopher Porter, MD is a Urology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174616437.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Porter, MD has received a total of $4,916 in payments from pharmaceutical and medical device companies, with $698.78 received in 2024. These payments were reported across 63 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($4,743).
As a Medicare-enrolled provider, Porter has provided services to 1,350 Medicare beneficiaries, totaling 1,532 services with total Medicare billing of $103,380. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Seattle, WA
- Active Since 10/01/2006
- Last Updated 10/07/2010
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1174616437
Products in Payments
- INTERSTIM (Device) $2,451
- Xtandi (Drug) $275.92
- XTANDI (Drug) $207.56
- PENILE RECONSTRUCTION (Device) $203.38
- AdVance XP (Device) $155.99
- Pedmark (Drug) $136.66
- INTERSTIM ICON (Device) $132.15
- Echelon Flex (Device) $131.00
- Lupron (Drug) $114.82
- HEMOSPRAY (Device) $106.21
- Cook Medical Holmium Laser Fiber (Device) $105.17
- GENTLECATH (Device) $103.81
- SPEEDICATH (Device) $103.29
- Erleada (Drug) $79.98
- ERLEADA (Drug) $71.71
- Valleylab FT10 (Device) $62.96
- 09 PROMO FLEX-X FLEX URETEROSCOPE, 7.5F (Device) $60.73
- SENSURA MIO CONVEX (Device) $34.09
- (815) Thiola (Drug) $3.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Seattle
Dr. James Porter, M.d, M.D
Urology — Payments: $764,015
Cristopher Garlitz, M.d, M.D
Urology — Payments: $303,210
Dr. Thomas Walsh, M.d, M.D
Urology — Payments: $279,672
Marah Hehemann, M.d, M.D
Urology — Payments: $264,034
Una Lee, M.d, M.D
Urology — Payments: $131,923
Alvaro Lucioni, M.d, M.D
Urology — Payments: $57,879